-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation
-
Early-phase oncology clinical trial design in the era of molecularly targeted therapy: pitfalls and progress
Penelope Bradbury, John Hilton , Lesley Seymour
Review Article: Clinical Investigation